386 related articles for article (PubMed ID: 24392842)
41. High Mobility Group Protein 1 Reverses Immune System Paralysis in Late-Phase Sepsis.
Liu QY; Wang YX; Wu ZS; Shi ZW; Wu X; Chen X; Yang Z; Xu KZ
Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29941462
[TBL] [Abstract][Full Text] [Related]
42. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies.
Musumeci D; Roviello GN; Montesarchio D
Pharmacol Ther; 2014 Mar; 141(3):347-57. PubMed ID: 24220159
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of high-mobility group box 1 as therapeutic option in autoimmune disease: lessons from animal models.
Schaper F; Heeringa P; Bijl M; Westra J
Curr Opin Rheumatol; 2013 Mar; 25(2):254-9. PubMed ID: 23249831
[TBL] [Abstract][Full Text] [Related]
44. The cytokine activity of HMGB1.
Yang H; Wang H; Czura CJ; Tracey KJ
J Leukoc Biol; 2005 Jul; 78(1):1-8. PubMed ID: 15734795
[TBL] [Abstract][Full Text] [Related]
45. HMGB1 as a DNA-binding cytokine.
Andersson U; Erlandsson-Harris H; Yang H; Tracey KJ
J Leukoc Biol; 2002 Dec; 72(6):1084-91. PubMed ID: 12488489
[TBL] [Abstract][Full Text] [Related]
46. Structure-based design of glycyrrhetinic acid derivatives as potent anti-sepsis agents targeting high-mobility group box-1.
Wang Y; Yu Z; Yuan H; Chen H; Xie N; Wang Z; Sun Q; Zhang W
Bioorg Chem; 2021 Jan; 106():104461. PubMed ID: 33223202
[TBL] [Abstract][Full Text] [Related]
47. The role of high mobility group box-1 protein in severe sepsis.
Sunden-Cullberg J; Norrby-Teglund A; Treutiger CJ
Curr Opin Infect Dis; 2006 Jun; 19(3):231-6. PubMed ID: 16645483
[TBL] [Abstract][Full Text] [Related]
48. Delayed administration of D-Ala2-D-Leu5-enkephalin, a delta-opioid receptor agonist, improves survival in a rat model of sepsis.
Tang CW; Feng WM; Du HM; Bao Y; Zhu M
Tohoku J Exp Med; 2011 May; 224(1):69-76. PubMed ID: 21551984
[TBL] [Abstract][Full Text] [Related]
49. High Mobility Group Box 1 (HMGB1): Potential Target in Sepsis-Associated Encephalopathy.
DeWulf B; Minsart L; Verdonk F; Kruys V; Piagnerelli M; Maze M; Saxena S
Cells; 2023 Apr; 12(7):. PubMed ID: 37048161
[TBL] [Abstract][Full Text] [Related]
50. Neuropeptides rescue mice from lethal sepsis by down-regulating secretion of the late-acting inflammatory mediator high mobility group box 1.
Chorny A; Delgado M
Am J Pathol; 2008 May; 172(5):1297-307. PubMed ID: 18385521
[TBL] [Abstract][Full Text] [Related]
51. High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics.
Vijayakumar EC; Bhatt LK; Prabhavalkar KS
Curr Drug Targets; 2019; 20(14):1474-1485. PubMed ID: 31215389
[TBL] [Abstract][Full Text] [Related]
52. High-mobility group box 1 in Parkinson's disease: from pathogenesis to therapeutic approaches.
Angelopoulou E; Piperi C; Papavassiliou AG
J Neurochem; 2018 Aug; 146(3):211-218. PubMed ID: 29676481
[TBL] [Abstract][Full Text] [Related]
53. Tolerization with BLP down-regulates HMGB1 a critical mediator of sepsis-related lethality.
Coffey JC; Wang JH; Kelly R; Romics L; O'Callaghan A; Fiuza C; Redmond HP
J Leukoc Biol; 2007 Oct; 82(4):906-14. PubMed ID: 17626148
[TBL] [Abstract][Full Text] [Related]
54. A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1.
Li W; Li J; Ashok M; Wu R; Chen D; Yang L; Yang H; Tracey KJ; Wang P; Sama AE; Wang H
J Immunol; 2007 Mar; 178(6):3856-64. PubMed ID: 17339485
[TBL] [Abstract][Full Text] [Related]
55. HMGB1 is a promising therapeutic target for acute liver failure.
Yamamoto T; Tajima Y
Expert Rev Gastroenterol Hepatol; 2017 Jul; 11(7):673-682. PubMed ID: 28657371
[TBL] [Abstract][Full Text] [Related]
56. Inflammatory response and immune regulation of high mobility group box-1 protein in treatment of sepsis.
Liu QY; Yao YM
World J Emerg Med; 2010; 1(2):93-8. PubMed ID: 25214948
[TBL] [Abstract][Full Text] [Related]
57. Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis.
Susa Y; Masuda Y; Imaizumi H; Namiki A
Crit Care Med; 2009 Sep; 37(9):2619-24. PubMed ID: 19623040
[TBL] [Abstract][Full Text] [Related]
58. Anti-high-mobility group box chromosomal protein 1 antibodies improve survival of rats with sepsis.
Suda K; Kitagawa Y; Ozawa S; Saikawa Y; Ueda M; Ebina M; Yamada S; Hashimoto S; Fukata S; Abraham E; Maruyama I; Kitajima M; Ishizaka A
World J Surg; 2006 Sep; 30(9):1755-62. PubMed ID: 16850155
[TBL] [Abstract][Full Text] [Related]
59. Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator.
Erlandsson Harris H; Andersson U
Eur J Immunol; 2004 Jun; 34(6):1503-12. PubMed ID: 15162419
[TBL] [Abstract][Full Text] [Related]
60. Role of HMGB1 in apoptosis-mediated sepsis lethality.
Qin S; Wang H; Yuan R; Li H; Ochani M; Ochani K; Rosas-Ballina M; Czura CJ; Huston JM; Miller E; Lin X; Sherry B; Kumar A; Larosa G; Newman W; Tracey KJ; Yang H
J Exp Med; 2006 Jul; 203(7):1637-42. PubMed ID: 16818669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
